Gene expression profiles between the palbociclib monotherpy versus palbociclib alternating with ICI182,780 treatment in breast cancer cells at 10 weeks.
Ontology highlight
ABSTRACT: We examined differential gene expression profiles between MCF7 human breast cancer cells treated with vehicle alone (control), palbociclib monotherapy, palbociclib alternating with ICI182,780 treatment, and palbociclib resistant cells. For this, we used gene microarray expression profiling to identify significantly changed genes under different treatment conditions.
ORGANISM(S): Homo sapiens
PROVIDER: GSE229002 | GEO | 2023/04/10
REPOSITORIES: GEO
ACCESS DATA